Closed System Drug Transfer Devices


This is a new and comprehensive report researched and written by Greystone Research Associates. The report – Closed System Drug Transfer: Products, Players and Prospects – includes detailed assessments of devices and therapeutic market segments, analysis of market factors, market data and forecasts by region, and profiles of market participants.



Interest in closed system drug transfer devices has been growing as regulatory activity and practitioner awareness surrounding hazardous drug compounding and administration continue to increase. Drugs deemed hazardous to humans have been receiving increasing amounts of scrutiny in recent years as the dangers of these substances become more clearly understood. For caregivers and their patients, the therapeutic area that is at the forefront of attempts to mitigate exposure to hazardous drugs is clinical oncology, a field that – in spite of promising new drugs based on therapeutic antibodies – continues to rely heavily on antineoplastics, a class that includes alkylating agents and antimetabolites, to treat a wide range of cancers.